Robert L Giuntoli II, M.D.
Professor of Clinical Obstetrics and Gynecology
Attending, Gynecologic Oncology, Department of Obstetrics and Gynecology, Hospital of the University of Pennsylvania, Philadelphia, PA
Director, Gynecologic Oncology, Chester County Hospital, West Chester, PA
Attending, Gynecologic Oncology, Department of Obstetrics and Gynecology, Pennsylvania Hospital, Philadelphia, PA
Attending , Department of Surgery, Children's Hospital of Philadelphia, PA
Department: Obstetrics and Gynecology
Contact information
Jordan Center for Gynecologic Oncology at Penn Perelman Center for Advanced Medicine
3400 Civic Center Blvd.
10th Floor South
Philadelphia, PA 19104
3400 Civic Center Blvd.
10th Floor South
Philadelphia, PA 19104
Office: 800-789-7366
Education:
B.A. (Biology)
University of Pennsylvania, Philadelphia, PA, 1990.
M.D.
University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA, 1994.
Permanent linkB.A. (Biology)
University of Pennsylvania, Philadelphia, PA, 1990.
M.D.
University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA, 1994.
Selected Publications
Caruso G, Ainio C, Fumagalli D, Reynolds EA, Nasioudis D, Mc Gree ME, Fought AJ, Giuntoli RL, Mariani A, Cliby WA.: Textbook oncologic outcome in endometrial cancer surgery: A quality measure to improve survival and address disparities. Gynecol Oncol 200: 33-43, Jul 2025.Tubridy E, Gysler S, Latif NA, Ko EM, Giuntoli RL 2nd, Kim SH, Nasioudis D.: Role of lymphadenectomy for apparent early-stage low-grade serous ovarian carcinoma. Int J Gynecol Cancer 2025.
Mulugeta-Gordon L, Gysler S, Latif NA, Ko EM, Giuntoli RL 2nd, Kim SH, Nasioudis D.: Quality of adjuvant radiation therapy and impact on the survival of patients with lymph node-positive squamous cell carcinoma of the vulva. Int J Gynecol Cancer 2025.
Caruso G, Kumar A, Langstraat CL, McGree ME, Fought AJ, Harrington S, Nasioudis D, Aletti GD, Colombo N, Giuntoli RL, Cliby W.: Racial/ethnic, socioeconomic, and healthcare access disparities in achieving textbook oncologic outcome in advanced ovarian cancer. Gynecol Oncol 2025.
Nasioudis D, Gysler S, Latif NA, Giuntoli RL 2nd, Kim SH, Ko EM.: Incidence of lymph node metastases in patients with apparent early-stage endometrioid ovarian carcinoma. Int J Gynecol Cancer 2025.
Nasioudis D, Labban N, Gysler S, Ko EM, Giuntoli RL 2nd, Kim SH, Latif NA: Outcomes of Radical Hysterectomy for Early-Stage Cervical Carcinoma, with or without Prior Cervical Excision Procedure. Cancers (Basel) 16(11):2051, May 2024.
Nasioudis D, Gysler S, Latif NA, Giuntoli RL 2nd, Kim SH, Ko EM: Role of systematic lymphadenectomy at the time of interval debulking surgery for patients with advanced-stage epithelial ovarian carcinoma who achieved complete gross resection. Int J Gynecol Cancer 34(7):969-974, May 2024.
Nasioudis D, Gysler S, Latif N, Cory L, Giuntoli RL 2nd, Kim SH, Simpkins F, Martin L, Ko EM: Molecular landscape of ERBB2/HER2 gene amplification among patients with gynecologic malignancies; clinical implications and future directions. Gynecol Oncol 180:1-5, Jan 2024.
Nasioudis D, Wang X, Dhillon G, Latif N, Ko EM, Giuntoli RL 2nd, Gershenson D, Fader A, Carey M, Simpkins F: Impact of adjuvant chemotherapy on the overall survival of patients with advanced-stage low-grade serous ovarian carcinoma following primary cytoreductive surgery. Int J Gynecol Cancer Page: 33(12):1906-1912, Dec 2023.
Nasioudis D, Arevalo O, Gysler S, Ko EM, Cory L, Kim SH, Giuntoli RL 2nd, Latif NA: Impact of delayed interval cytoreductive surgery on the survival of patients with advanced stage high-grade epithelial ovarian carcinoma. Int J Gynecol Cancer ijgc-2023-004805, Dec 2023.